dexloxiglumide dexloxiglumide dexloxiglumide is a drug which acts as a cholecystokinin antagonist, selective for the ccka subtype. it inhibits gastrointestinal motility and reduces gastric secretions, and despite older selective ccka antagonists such as lorglumide and devazepide having had only limited success in trials and ultimately never making it into clinical use, dexloxiglumide is being investigated as a potential treatment for a variety of gastrointestinal problems including irritable bowel syndrome, dyspepsia, constipation and pancreatitis, and has had moderate success so far although trials are still ongoing. dexloxiglumideclinical dataatc codenoneidentifiers iupac name (4r)-4--5-(3-methoxypropylpentylamino)-5-oxopentanoic acid cas number119817-90-2 ypubchem cid65937iuphar/bps889chemspider59342 nunii69dy40rh9bchemblchembl550781 ncomptox dashboard (epa)dtxsid50152604 chemical and physical dataformulac21h30cl2n2o5molar mass461.38 g·mol−13d model (jsmol)interactive image smiles cccccn(cccoc)c(=o)(ccc(=o)o)nc(=o)c1=cc(=c(c=c1)cl)cl inchi inchi=1s/c21h30cl2n2o5/c1-3-4-5-11-25(12-6-13-30-2)21(29)18(9-10-19(26)27)24-20(28)15-7-8-16(22)17(23)14-15/h7-8,14,18h,3-6,9-13h2,1-2h3,(h,24,28)(h,26,27)/t18-/m1/s1 nkey:qnqzbkqeifthfz-gosisdbhsa-n n ny (what is this?) (verify)